Ebola Drugs a Low Priority for Pharmaceutical Companies
Written by Pat Papers | Wednesday, 6 August 2014 8:47 AM
While the world experiences the deadliest Ebola outbreak ever, the disease remains one that has no drugs to treat it. The San Francisco Chronicle says drug makers have little incentive to spend time and money on a disease that predominantly affects people in impoverished countries. Health officials tell the Chronicle this outbreak could encourage pharmaceutical companies to speed up the development process or lead small groups in risky drug trials.
SOURCE: San Francisco Chronicle
Now in Bookstores
Pat’s picture book is a perfect gift for anyone between the ages of 2 and 6.
Listen and Subscribe
Pat Kiernan and Jamie Stelter talk to New Yorkers about New York. Online and Live at 92Y.